Vasopressors in cardiac arrest: A systematic review

Resuscitation

Volumn 83, Issue 8, 2012, Pages 932-939

  Larabee, Todd M ^a   Liu, Kirsten Y ^b   Campbell, Jenny A ^a   Little, Charles M ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

Advanced life support; Cardiac arrest; Pediatric resuscitation; Resuscitation; Vasopressor

Indexed keywords

ADRENALIN; DOPAMINE; HYPERTENSIVE AGENT; METHOXAMINE; METHYLPREDNISOLONE; NORADRENALIN; PHENYLEPHRINE; PLACEBO; TERLIPRESSIN; VASOPRESSIN;

CHILD CARE; COMBINATION CHEMOTHERAPY; DOSE RESPONSE; DRUG MEGADOSE; HEART ARREST; HUMAN; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SIDE EFFECT; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

CARDIOPULMONARY RESUSCITATION; DRUG THERAPY, COMBINATION; EPINEPHRINE; HEART ARREST; HUMANS; LIFE SUPPORT CARE; NOREPINEPHRINE; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 84863819076     PISSN: 03009572     EISSN: 18731570     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2012.02.029     Document Type: Short Survey

References (67)

1. Mehra R. Global public health problem of sudden cardiac death. J Electrocardiol 2007, 40:S118-S122.
2. Zheng Z.J., Croft J.B., Giles W.H., Mensah G.A. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001, 104:2158-2163.
3. Escobedo L.G., Zack M.M. Comparison of sudden and nonsudden coronary deaths in the United States. Circulation 1996, 93:2033-2036.
4. Mokdad A.H., Marks J.S., Stroup D.F., Gerberding J.L. Actual causes of death in the United States, 2000. JAMA 2004, 291:1238-1245.
5. Chugh S.S., Jui J., Gunson K., et al. Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. J Am Coll Cardiol 2004, 44:1268-1275.
6. Nichol G., Stiell I.G., Laupacis A., Pham B., De Maio V.J., Wells G.A. A cumulative meta-analysis of the effectiveness of defibrillator-capable emergency medical services for victims of out-of-hospital cardiac arrest. Ann Emerg Med 1999, 34:517-525.
7. Peberdy M.A., Kaye W., Ornato J.P., et al. Cardiopulmonary resuscitation of adults in the hospital: a report of 14720 cardiac arrests from the National Registry of Cardiopulmonary Resuscitation. Resuscitation 2003, 58:297-308.
8. Penson P.E., Ford W.R., Broadley K.J. Vasopressors for cardiopulmonary resuscitation. Does pharmacological evidence support clinical practice?. Pharmacol Ther 2007, 115:37-55.
9. Tang W., Weil M.H., Sun S., Noc M., Yang L., Gazmuri R.J. Epinephrine increases the severity of postresuscitation myocardial dysfunction. Circulation 1995, 92:3089-3093.
10. Ristagno G., Sun S., Tang W., Castillo C., Weil M.H. Effects of epinephrine and vasopressin on cerebral microcirculatory flows during and after cardiopulmonary resuscitation. Crit Care Med 2007, 35:2145-2149.
11. Ristagno G., Tang W., Huang L., et al. Epinephrine reduces cerebral perfusion during cardiopulmonary resuscitation. Crit Care Med 2009, 37:1408-1415.
12. Morley P.T. Evidence evaluation worksheets: the systematic reviews for the evidence evaluation process for the 2010 International Consensus on Resuscitation Science. Resuscitation 2009, 80:719-721.
13. Olasveengen T.M., Sunde K., Brunborg C., Thowsen J., Steen P.A., Wik L. Intravenous drug administration during out-of-hospital cardiac arrest: a randomized trial. JAMA 2009, 302:2222-2229.
14. Woodhouse S.P., Cox S., Boyd P., Case C., Weber M. High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation 1995, 30:243-249.
15. Herlitz J., Ekstrom L., Wennerblom B., Axelsson A., Bang A., Holmberg S. Adrenaline in out-of-hospital ventricular fibrillation. Does it make any difference?. Resuscitation 1995, 29:195-201.
16. Ong M.E., Tan E.H., Ng F.S., et al. Survival outcomes with the introduction of intravenous epinephrine in the management of out-of-hospital cardiac arrest. Ann Emerg Med 2007, 50:635-642.
17. Jacobs I.G., Finn J.C., Jelinek G.A., Oxer H.F., Thompson P.L. Effect of adrenaline on survival in out-of-hospital cardiac arrest: a randomised double-blind placebo-controlled trial. Resuscitation 2011, 82:1138-1143.
18. Morris D.C., Dereczyk B.E., Grzybowski M., et al. Vasopressin can increase coronary perfusion pressure during human cardiopulmonary resuscitation. Acad Emerg Med 1997, 4:878-883.
19. Mayr V., Luckner G., Jochberger S., et al. Arginine vasopressin in advanced cardiovascular failure during the post-resuscitation phase after cardiac arrest. Resuscitation 2007, 72:35-44.
20. Mally S., Jelatancev A., Grmec S. Effects of epinephrine and vasopressin on end-tidal carbon dioxide tension and mean arterial blood pressure in out-of-hospital cardiopulmonary resuscitation: an observational study. Crit Care 2007, 11:R39.
21. Ducros L., Vicaut E., Soleil C., et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. J Emerg Med 2011, 41:453-459.
22. Lindner K.H., Haak T., Keller A., Bothner U., Lurie K.G. Release of endogenous vasopressors during and after cardiopulmonary resuscitation. Heart 1996, 75:145-150.
23. Lindner K.H., Prengel A.W., Brinkmann A., Strohmenger H.U., Lindner I.M., Lurie K.G. Vasopressin administration in refractory cardiac arrest. Ann Intern Med 1996, 124:1061-1064.
24. Lindner K.H., Dirks B., Strohmenger H.U., Prengel A.W., Lindner I.M., Lurie K.G. Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation. Lancet 1997, 349:535-537.
25. Wenzel V., Krismer A.C., Arntz H.R., Sitter H., Stadlbauer K.H., Lindner K.H. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med 2004, 350:105-113.
26. Stiell I.G., Hebert P.C., Wells G.A., et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet 2001, 358:105-109.
27. Aung K., Htay T. Vasopressin for cardiac arrest: a systematic review and meta-analysis. Arch Intern Med 2005, 165:17-24.
28. Mukoyama T., Kinoshita K., Nagao K., Tanjoh K. Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation. Resuscitation 2009, 80:755-761.
29. Grmec S., Mally S. Vasopressin improves outcome in out-of-hospital cardiopulmonary resuscitation of ventricular fibrillation and pulseless ventricular tachycardia: a observational cohort study. Crit Care 2006, 10:R13.
30. Callaway C.W., Hostler D., Doshi A.A., et al. Usefulness of vasopressin administered with epinephrine during out-of-hospital cardiac arrest. Am J Cardiol 2006, 98:1316-1321.
31. Gueugniaud P.Y., David J.S., Chanzy E., et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. N Engl J Med 2008, 359:21-30.
32. Guyette F.X., Guimond G.E., Hostler D., Callaway C.W. Vasopressin administered with epinephrine is associated with a return of a pulse in out-of-hospital cardiac arrest. Resuscitation 2004, 63:277-282.
33. Mentzelopoulos S.D., Zakynthinos S.G., Tzoufi M., et al. Vasopressin, epinephrine, and corticosteroids for in-hospital cardiac arrest. Arch Intern Med 2009, 169:15-24.
34. Cody P., Lauderdale S., Hogan D.E., Frantz R.R. Comparison of two protocols for pulseless cardiopulmonary arrest: vasopressin combined with epinephrine versus epinephrine alone. Prehosp Disaster Med 2010, 25:420-423.
35. Gonzalez E.R., Ornato J.P., Garnett A.R., Levine R.L., Young D.S., Racht E.M. Dose-dependent vasopressor response to epinephrine during CPR in human beings. Ann Emerg Med 1989, 18:920-926.
36. Barton C., Callaham M. High-dose epinephrine improves the return of spontaneous circulation rates in human victims of cardiac arrest. Ann Emerg Med 1991, 20:722-725.
37. Paradis N.A., Martin G.B., Rosenberg J., et al. The effect of standard- and high-dose epinephrine on coronary perfusion pressure during prolonged cardiopulmonary resuscitation. JAMA 1991, 265:1139-1144.
38. Lindner K.H., Ahnefeld F.W., Prengel A.W. Comparison of standard and high-dose adrenaline in the resuscitation of asystole and electromechanical dissociation. Acta Anaesthesiol Scand 1991, 35:253-256.
39. Callaham M., Barton C.W., Kayser S. Potential complications of high-dose epinephrine therapy in patients resuscitated from cardiac arrest. JAMA 1991, 265:1117-1122.
40. Behringer W., Kittler H., Sterz F., et al. Cumulative epinephrine dose during cardiopulmonary resuscitation and neurologic outcome. Ann Intern Med 1998, 129:450-456.
41. Carvolth R.D., Hamilton A.J. Comparison of high-dose epinephrine versus standard-dose epinephrine in adult cardiac arrest in the prehospital setting. Prehosp Disaster Med 1996, 11:219-222.
42. Rivers E.P., Wortsman J., Rady M.Y., Blake H.C., McGeorge F.T., Buderer N.M. The effect of the total cumulative epinephrine dose administered during human CPR on hemodynamic, oxygen transport, and utilization variables in the postresuscitation period. Chest 1994, 106:1499-1507.
43. Chang W.T., Ma M.H., Chien K.L., et al. Postresuscitation myocardial dysfunction: correlated factors and prognostic implications. Intensive Care Med 2007, 33:88-95.
44. Brown C.G., Martin D.R., Pepe P.E., et al. A comparison of standard-dose and high-dose epinephrine in cardiac arrest outside the hospital. The Multicenter High-Dose Epinephrine Study Group. N Engl J Med 1992, 327:1051-1055.
45. Choux C., Gueugniaud P.Y., Barbieux A., et al. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation 1995, 29:3-9.
46. Callaham M., Madsen C., Barton C., Saunders C., Daley M., Pointer J. A randomized clinical trial of high-dose epinephrine and norepinephrine versus standard-dose epinephrine in prehospital cardiac arrest. JAMA 1992, 268:2667-2672.
47. Gueugniaud P.Y., Mols P., Goldstein P., et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. European Epinephrine Study Group. N Engl J Med 1998, 339:1595-1601.
48. Lipman J., Wilson W., Kobilski S., et al. High-dose adrenaline in adult in-hospital asystolic cardiopulmonary resuscitation: a double-blind randomised trial. Anaesth Intensive Care 1993, 21:192-196.
49. Stiell I.G., Hebert P.C., Weitzman B.N., et al. High-dose epinephrine in adult cardiac arrest. N Engl J Med 1992, 327:1045-1050.
50. Sherman B.W., Munger M.A., Foulke G.E., Rutherford W.F., Panacek E.A. High-dose versus standard-dose epinephrine treatment of cardiac arrest after failure of standard therapy. Pharmacotherapy 1997, 17:242-247.
51. Vandycke C., Martens P. High dose versus standard dose epinephrine in cardiac arrest - a meta-analysis. Resuscitation 2000, 45:161-166.
52. Olson D.W., Thakur R., Stueven H.A., et al. Randomized study of epinephrine versus methoxamine in prehospital ventricular fibrillation. Ann Emerg Med 1989, 18:250-253.
53. Patrick W.D., Freedman J., McEwen T., Light R.B., Ludwig L., Roberts D. A randomized, double-blind comparison of methoxamine and epinephrine in human cardiopulmonary arrest. Am J Respir Crit Care Med 1995, 152:519-523.
54. Turner L.M., Parsons M., Luetkemeyer R.C., Ruthman J.C., Anderson R.J., Aldag J.C. A comparison of epinephrine and methoxamine for resuscitation from electromechanical dissociation in human beings. Ann Emerg Med 1988, 17:443-449.
55. Lindner K.H., Ahnefeld F.W., Grunert A. Epinephrine versus norepinephrine in prehospital ventricular fibrillation. Am J Cardiol 1991, 67:427-428.
56. Gonzalez E.R., Ornato J.P., Levine R.L. Vasopressor effect of epinephrine with and without dopamine during cardiopulmonary resuscitation. Drug Intell Clin Pharm 1988, 22:868-872.
57. Silfvast T., Saarnivaara L., Kinnunen A., et al. Comparison of adrenaline and phenylephrine in out-of-hospital cardiopulmonary resuscitation. A double-blind study. Acta Anaesthesiol Scand 1985, 29:610-613.
58. Carpenter T.C., Stenmark K.R. High-dose epinephrine is not superior to standard-dose epinephrine in pediatric in-hospital cardiopulmonary arrest. Pediatrics 1997, 99:403-408.
59. Dieckmann R.A., Vardis R. High-dose epinephrine in pediatric out-of-hospital cardiopulmonary arrest. Pediatrics 1995, 95:901-913.
60. Goetting M.G., Paradis N.A. High dose epinephrine in refractory pediatric cardiac arrest. Crit Care Med 1989, 17:1258-1262.
61. Goetting M.G., Paradis N.A. High-dose epinephrine improves outcome from pediatric cardiac arrest. Ann Emerg Med 1991, 20:22-26.
62. Patterson M.D., Boenning D.A., Klein B.L., et al. The use of high-dose epinephrine for patients with out-of-hospital cardiopulmonary arrest refractory to prehospital interventions. Pediatr Emerg Care 2005, 21:227-237.
63. Perondi M.B., Reis A.G., Paiva E.F., Nadkarni V.M., Berg R.A. A comparison of high-dose and standard-dose epinephrine in children with cardiac arrest. N Engl J Med 2004, 350:1722-1730.
64. Duncan J.M., Meaney P., Simpson P., Berg R.A., Nadkarni V., Schexnayder S. Vasopressin for in-hospital pediatric cardiac arrest: results from the American Heart Association National Registry of Cardiopulmonary Resuscitation. Pediatr Crit Care Med 2009, 10:191-195.
65. Matok I., Vardi A., Augarten A., et al. Beneficial effects of terlipressin in prolonged pediatric cardiopulmonary resuscitation: a case series. Crit Care Med 2007, 35:1161-1164.
66. Yldzdas D., Horoz O.O., Erdem S. Beneficial effects of terlipressin in pediatric cardiac arrest. Pediatr Emerg Care 2011, 27:865-868.
67. Carroll TG, Dimas VV, Raymond TT. Vasopressin rescue for in-pediatric intensive care unit cardiopulmonary arrest refractory to initial epinephrine dosing: a prospective feasibility pilot trial. Pediatr Crit Care Med 2011 September 15 [epub ahead of print].